CTOR (STOCKS)
Citius Oncology, Inc. Common Stock
$1.060000
-0.070000 (-6.19%)
Prev close: $1.130000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Leonard L. Mazur
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $100.63M
- Employees
- —
- P/E (TTM)
- -3.34
- P/B (TTM)
- 2.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$181.66K |
| Operating Expenses | $23.52M |
| Research and Development | $6.42M |
| Other Operating Expenses | $17.10M |
| Operating Income/Loss | -$23.52M |
| Income/Loss From Continuing Operations After Tax | -$24.76M |
| Income/Loss From Continuing Operations Before Tax | -$23.70M |
| Income Tax Expense/Benefit | $1.06M |
| Income Tax Expense/Benefit, Deferred | $1.06M |
| Interest Expense, Operating | $218.03K |
| Net Income/Loss | -$24.76M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$24.76M |
| Net Income/Loss Available To Common Stockholders, Basic | -$24.76M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.34 |
| Diluted Earnings Per Share | -$0.34 |
| Basic Average Shares | 73,267,969 |
| Diluted Average Shares | 73,267,969 |
| Assets | $100.94M |
| Current Assets | $27.54M |
| Inventory | $22.29M |
| Prepaid Expenses | $1.33M |
| Other Current Assets | $3.92M |
| Noncurrent Assets | $73.40M |
| Liabilities | $56.08M |
| Current Liabilities | $49.49M |
| Accounts Payable | $13.23M |
| Other Current Liabilities | $36.26M |
| Noncurrent Liabilities | $6.59M |
| Equity | $44.87M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $44.87M |
| Liabilities And Equity | $100.94M |
| Net Cash Flow From Operating Activities | -$5.49M |
| Net Cash Flow From Operating Activities, Continuing | -$5.49M |
| Net Cash Flow From Investing Activities | -$5.75M |
| Net Cash Flow From Investing Activities, Continuing | -$5.75M |
| Net Cash Flow From Financing Activities | $15.17M |
| Net Cash Flow From Financing Activities, Continuing | $15.17M |
| Net Cash Flow | $3.92M |
| Net Cash Flow, Continuing | $3.92M |
| Comprehensive Income/Loss | -$24.76M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$24.76M |
| Other Comprehensive Income/Loss | $0.00 |